During the past decade, Idaho Allergy and Research conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Idaho Allergy and Research" are "Peanut Allergy" (3 trials), "Allergic Rhinitis" (1 trials), "Dermatitis" (1 trials), "Dermatitis, Atopic" (1 trials) and "Eczema" (1 trials). Many other conditions were trialed in "Idaho Allergy and Research" in a lesser frequency.

Most popular intervention types in "Idaho Allergy and Research" are "Biological" (3 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "AR101" (3 trials), "Placebo" (2 trials), "Azelastine hydrochloride nasal spray 0.10%" (1 trials), "Azelastine hydrochloride nasal spray 0.15%" (1 trials) and "Dupilumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Idaho Allergy and Research" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Idaho Allergy and Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Idaho Allergy and Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Idaho Allergy and Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".